Nitroglycerin API Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends
Top Countries — Revenue
Access the full forecast model.
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
Nitroglycerin API Market Analysis — Presence
Geographical Analysis
Click countries to exploreRegional and Country Analysis
Global Nitroglycerin API Market Analysis 2026
| Region / Country | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|---|---|---|---|
| Global | xxxx | xxxx | xxxx | 6% |
| North America | xxxx | xxxx | xxxx | 4.2% |
| United States | xxxx | xxxx | xxxx | xxxx |
| Canada | xxxx | xxxx | xxxx | xxxx |
| Mexico | xxxx | xxxx | xxxx | xxxx |
| Europe | xxxx | xxxx | xxxx | 4.5% |
| United Kingdom | xxxx | xxxx | xxxx | xxxx |
| France | xxxx | xxxx | xxxx | xxxx |
| Germany | xxxx | xxxx | xxxx | xxxx |
| Italy | xxxx | xxxx | xxxx | xxxx |
| Russia | xxxx | xxxx | xxxx | xxxx |
| Spain | xxxx | xxxx | xxxx | xxxx |
| Sweden | xxxx | xxxx | xxxx | xxxx |
| Denmark | xxxx | xxxx | xxxx | xxxx |
| Switzerland | xxxx | xxxx | xxxx | xxxx |
| Luxembourg | xxxx | xxxx | xxxx | xxxx |
| Rest of Europe | xxxx | xxxx | xxxx | xxxx |
| Asia Pacific | xxxx | xxxx | xxxx | 8% |
| China | xxxx | xxxx | xxxx | xxxx |
| Japan | xxxx | xxxx | xxxx | xxxx |
| South Korea | xxxx | xxxx | xxxx | xxxx |
| India | xxxx | xxxx | xxxx | xxxx |
| Australia | xxxx | xxxx | xxxx | xxxx |
| Singapore | xxxx | xxxx | xxxx | xxxx |
| Taiwan | xxxx | xxxx | xxxx | xxxx |
| South East Asia | xxxx | xxxx | xxxx | xxxx |
| Rest of APAC | xxxx | xxxx | xxxx | xxxx |
| South America | xxxx | xxxx | xxxx | 5.4% |
| Brazil | xxxx | xxxx | xxxx | xxxx |
| Argentina | xxxx | xxxx | xxxx | xxxx |
| Colombia | xxxx | xxxx | xxxx | xxxx |
| Peru | xxxx | xxxx | xxxx | xxxx |
| Chile | xxxx | xxxx | xxxx | xxxx |
| Rest of South America | xxxx | xxxx | xxxx | xxxx |
| Middle East | xxxx | xxxx | xxxx | 5.7% |
| Saudi Arabia | xxxx | xxxx | xxxx | xxxx |
| Turkey | xxxx | xxxx | xxxx | xxxx |
| UAE | xxxx | xxxx | xxxx | xxxx |
| Egypt | xxxx | xxxx | xxxx | xxxx |
| Qatar | xxxx | xxxx | xxxx | xxxx |
| Rest of Middle East | xxxx | xxxx | xxxx | xxxx |
| Africa | xxxx | xxxx | xxxx | xxxx |
| East Africa | xxxx | xxxx | xxxx | xxxx |
| West Africa | xxxx | xxxx | xxxx | xxxx |
| North Africa | xxxx | xxxx | xxxx | xxxx |
| South Africa | xxxx | xxxx | xxxx | xxxx |
A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.
Unlock full regional dataset →Segmentation Analysis
Nitroglycerin API Market Type Segment Analysis The 10% NG variant represents a substantial portion of the market, indicating its significance in various applications. Its higher concentration implies potentially greater potency or efficacy in certain contexts, driving demand from industries such as pharmaceuticals, where precise dosages are critical for therapeutic effectiveness. Additionally, the 10% formulation can be used in specialized industrial applications where a stronger explosive is required, such as in mining or construction. In contrast, the 5% NG formulation, while comprising a smaller segment, still holds relevance. Its lower concentration may appeal to sectors prioritizing safety or requiring less intense reactions, such as certain medical applications or controlled explosive uses in military or industrial settings.
Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
Competitor Analysis
Competitive Landscape of the Nitroglycerin API Market
The Nitroglycerin API market exhibits a competitive landscape with key players vying for market share. Emerging players from Asia-Pacific pose a growing threat with their competitive pricing and expanding global presence. Overall, intense competition persists, driven by innovation, regulatory compliance, and market expansion strategies.
Cosette Pharmaceuticals, Inc. ("Cosette") announced that the U.S. Food and Drug Administration (FDA) has approved the Abbreviated New Drug Applications (ANDA) for the first generic version of RECTIV® (nitroglycerin) ointment, 0.4%, with 180 days Competitive Generic Therapy (CGT) exclusivity. Cosette will imminently commence commercial shipments, triggering the 180 days exclusivity. (Source: https://finance.yahoo.com/news/cosette-pharmaceuticals-announces-approval-launch-133000723.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAB9nnXT4DzttSfp2jKR1mHKx7UUoJa0Qzb73zY4-bmpcrAXag4cPlVaSfp43cXVR8rKzLZT_GP6bYAWOyFiFpzdqRRrttoL47NN4rkg6VWD-wDqHyil8EU3B3z16VzRFMpNuxB8o6F1qgc9PZs3RUa3g21orrICROvZ5QNSSJlrX)
| Top Companies (In no particular order) | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Novasep (France) | ••• | ••• | ••• | ••• |
| Copperhead Chemical (US.) | ••• | ••• | ••• | ••• |
| Dipharma (Italy) | ••• | ••• | ••• | ••• |
| Cambrex (US.) | ••• | ••• | ••• | ••• |
| Bharat Pharma (India) | ••• | ••• | ••• | ••• |
| SD Sinepharm (Beijing) | ••• | ••• | ••• | ••• |
| Dorsa Pharmaceutical (India) | ••• | ••• | ••• | ••• |
We Provide Regional Breakdown of this Companies and Company specific to any Country, Region, Product/ service as well. We cover market share analysis for publicly listed companies as well as privately held companies, subject to data availability.
Request company profile for validation →Report Scope & Analysis
According to Cognitive Market Research, the global Nitroglycerin API market size is USD 22.9 million in 2024 and will expand at a compound annual growth rate (CAGR) of 6.00% from 2024 to 2031.
- North America held the major market, accounting for more than 40% of global revenue. With a market size of USD 9.16 million in 2024, it will grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031.
- Europe accounted for a share of over 30% of the global market size of USD 6.87 million.
- Asia Pacific held the market of around 23% of the global revenue with a market size of USD 5.27 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.0% from 2024 to 2031.
- Latin America market will account for more than 5% of global revenue and was USD 1.15 million in 2024, growing at a compound annual growth rate (CAGR) of 5.4% from 2024 to 2031.
- Middle East and Africa held the markets, accounting for around 2% of global revenue. The market was USD 0.46 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2031.
- The 10% NG held the highest Nitroglycerin API market revenue share in 2024.
Introduction of the Nitroglycerin API Market
The Nitroglycerin API market is a vital segment within the pharmaceutical and explosive industries, driven by its diverse applications and demand across the globe. Nitroglycerin, a potent vasodilator, finds extensive use in treating angina pectoris and congestive heart failure, making it a cornerstone in cardiovascular medicine. Additionally, its explosive properties render it indispensable in mining, construction, and military applications. The market's growth is fueled by factors such as increasing incidence of cardiovascular diseases, rising healthcare expenditure, and expanding industrial activities. Moreover, ongoing research and development initiatives aimed at enhancing drug formulations and optimizing manufacturing processes contribute to market expansion.
Stringent regulations governing the production, storage, and transportation of nitroglycerin pose challenges for market players. Moreover, safety concerns regarding its explosive nature necessitate robust safety measures throughout the supply chain. Despite these challenges, the Nitroglycerin API market presents lucrative opportunities for pharmaceutical companies, chemical manufacturers, and explosives suppliers. Strategic collaborations, technological advancements, and expansion into emerging markets are key strategies adopted by industry players to capitalize on the growing demand for nitroglycerin-based products.
Analyst Conclusion
- The global Nitroglycerin API market will expand significantly by 6.00% CAGR between 2024 to 2031.
- 10% NG type stands out as the dominating category. With a 10% concentration, it maintains efficacy while mitigating risks. Demand is steady, balancing medical and industrial sectors.
- The dominating category is intravenous. Increasing incidences of heart diseases and advancements in healthcare infrastructure, with key players focusing on quality assurance and regulatory compliance.
Frequently Asked Questions
★ Reviews
Rate this report
Nitroglycerin API Market Analysis — Table of Contents
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
Report Scope
| Type | 10% NG, 5% NG, 2 15% NG. |
|---|---|
| End Use | Intravenous, Sublingual Spray, Nitroglycerin Patch |
| List of Competitors | Novasep (France), Copperhead Chemical (US.), Dipharma (Italy), Cambrex (US.), Bharat Pharma (India), SD Sinepharm (Beijing), Dorsa Pharmaceutical (India) |
Chapter 1. Competitor Analysis (Subject to Data Availability (Private Players))
- 1.1 Top Competitors Analysis
- 1.1.1 Global Nitroglycerin API Market Analysis by Key Players
- 1.1.2 Segment Market Analysis by Key Players
- 1.1.3 Top Players Ranking 2024
- 1.1.4 New Product Launch Analysis
- 1.1.5 Industry Mergers and Acquisition Analysis
- 1.2 Company Profile (Data Subject to Availability) Sample Format
- 1.2.1 Novasep (France)
- 1.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.1.2 Business Overview
- 1.2.1.3 Financials (Subject to data availability)
- 1.2.1.4 R&D Investment (Subject to data availability)
- 1.2.1.5 Product Types Specification
- 1.2.1.6 Business Strategy
- 1.2.1.7 Recent Developments
- 1.2.1.8 Management Change
- 1.2.1.9 S.W.O.T Analysis
- 1.2.2 Copperhead Chemical (US.)
- 1.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.2.2 Business Overview
- 1.2.2.3 Financials (Subject to data availability)
- 1.2.2.4 R&D Investment (Subject to data availability)
- 1.2.2.5 Product Types Specification
- 1.2.2.6 Business Strategy
- 1.2.2.7 Recent Developments
- 1.2.2.8 Management Change
- 1.2.2.9 S.W.O.T Analysis
- 1.2.3 Dipharma (Italy)
- 1.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.3.2 Business Overview
- 1.2.3.3 Financials (Subject to data availability)
- 1.2.3.4 R&D Investment (Subject to data availability)
- 1.2.3.5 Product Types Specification
- 1.2.3.6 Business Strategy
- 1.2.3.7 Recent Developments
- 1.2.3.8 Management Change
- 1.2.3.9 S.W.O.T Analysis
- 1.2.4 Cambrex (US.)
- 1.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.4.2 Business Overview
- 1.2.4.3 Financials (Subject to data availability)
- 1.2.4.4 R&D Investment (Subject to data availability)
- 1.2.4.5 Product Types Specification
- 1.2.4.6 Business Strategy
- 1.2.4.7 Recent Developments
- 1.2.4.8 Management Change
- 1.2.4.9 S.W.O.T Analysis
- 1.2.5 Bharat Pharma (India)
- 1.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.5.2 Business Overview
- 1.2.5.3 Financials (Subject to data availability)
- 1.2.5.4 R&D Investment (Subject to data availability)
- 1.2.5.5 Product Types Specification
- 1.2.5.6 Business Strategy
- 1.2.5.7 Recent Developments
- 1.2.5.8 Management Change
- 1.2.5.9 S.W.O.T Analysis
- 1.2.6 SD Sinepharm (Beijing)
- 1.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.6.2 Business Overview
- 1.2.6.3 Financials (Subject to data availability)
- 1.2.6.4 R&D Investment (Subject to data availability)
- 1.2.6.5 Product Types Specification
- 1.2.6.6 Business Strategy
- 1.2.6.7 Recent Developments
- 1.2.6.8 Management Change
- 1.2.6.9 S.W.O.T Analysis
- 1.2.7 Dorsa Pharmaceutical (India)
- 1.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.7.2 Business Overview
- 1.2.7.3 Financials (Subject to data availability)
- 1.2.7.4 R&D Investment (Subject to data availability)
- 1.2.7.5 Product Types Specification
- 1.2.7.6 Business Strategy
- 1.2.7.7 Recent Developments
- 1.2.7.8 Management Change
- 1.2.7.9 S.W.O.T Analysis
- 1.2.1 Novasep (France)
- 1.1 Top Competitors Analysis
Chapter 2. Global Nitroglycerin API Market Analysis
- 2.1 Global Nitroglycerin API Market Analysis
- 2.2 Global Nitroglycerin API Market Analysis by Region
- 2.3 Global Nitroglycerin API Market Analysis by Type
- 2.4 Global Nitroglycerin API Market Analysis by End Use
- 2.5 Global Nitroglycerin API Market Analysis by Key Players
Chapter 3. North America Nitroglycerin API Market Analysis
- 3.1 North America Nitroglycerin API Market Analysis
- 3.2 North America Nitroglycerin API Market Analysis by Country
- 3.3 North America Nitroglycerin API Market Analysis by Type
- 3.4 North America Nitroglycerin API Market Analysis by End Use
- 3.5 North America Nitroglycerin API Market Analysis by Key Players
Chapter 4. Europe Nitroglycerin API Market Analysis
- 4.1 Europe Nitroglycerin API Market Analysis
- 4.2 Europe Nitroglycerin API Market Analysis by Country
- 4.3 Europe Nitroglycerin API Market Analysis by Type
- 4.4 Europe Nitroglycerin API Market Analysis by End Use
- 4.5 Europe Nitroglycerin API Market Analysis by Key Players
Chapter 5. Asia Pacific Nitroglycerin API Market Analysis
- 5.1 Asia Pacific Nitroglycerin API Market Analysis
- 5.2 Asia Pacific Nitroglycerin API Market Analysis by Country
- 5.3 Asia Pacific Nitroglycerin API Market Analysis by Type
- 5.4 Asia Pacific Nitroglycerin API Market Analysis by End Use
- 5.5 Asia Pacific Nitroglycerin API Market Analysis by Key Players
Chapter 6. South America Nitroglycerin API Market Analysis
- 6.1 South America Nitroglycerin API Market Analysis
- 6.2 South America Nitroglycerin API Market Analysis by Country
- 6.3 South America Nitroglycerin API Market Analysis by Type
- 6.4 South America Nitroglycerin API Market Analysis by End Use
- 6.5 South America Nitroglycerin API Market Analysis by Key Players
Chapter 7. Middle East Nitroglycerin API Market Analysis
- 7.1 Middle East Nitroglycerin API Market Analysis
- 7.2 Middle East Nitroglycerin API Market Analysis by Country
- 7.3 Middle East Nitroglycerin API Market Analysis by Type
- 7.4 Middle East Nitroglycerin API Market Analysis by End Use
- 7.5 Middle East Nitroglycerin API Market Analysis by Key Players
Chapter 8. Africa Nitroglycerin API Market Analysis
- 8.1 Africa Nitroglycerin API Market Analysis
- 8.2 Africa Nitroglycerin API Market Analysis by Country
- 8.3 Africa Nitroglycerin API Market Analysis by Type
- 8.4 Africa Nitroglycerin API Market Analysis by End Use
- 8.5 Africa Nitroglycerin API Market Analysis by Key Players
Chapter 9. Type Analysis
- 9.1 10% NG
- 9.1.1 Global 10% NG Market
- 9.1.2 Global 10% NG Market by Region
- 9.2 5% NG
- 9.2.1 Global 5% NG Market
- 9.2.2 Global 5% NG Market by Region
- 9.3 2 15% NG.
- 9.3.1 Global 2 15% NG. Market
- 9.3.2 Global 2 15% NG. Market by Region
- 9.1 10% NG
Chapter 10. End Use Analysis
- 10.1 Intravenous
- 10.1.1 Global Intravenous Market
- 10.1.2 Global Intravenous Market by Region
- 10.2 Sublingual Spray
- 10.2.1 Global Sublingual Spray Market
- 10.2.2 Global Sublingual Spray Market by Region
- 10.3 Nitroglycerin Patch
- 10.3.1 Global Nitroglycerin Patch Market
- 10.3.2 Global Nitroglycerin Patch Market by Region
- 10.1 Intravenous
Chapter 11. Qualitative Analysis (Subject to Data Availability)
- 11.1 Market Drivers
- 11.2 Market Restraints
- 11.3 Market Trends
- 11.4 Market Opportunity
- 11.5 Technological Road Map (Subject to Data Availability)
- 11.6 Product Life Cycle (Subject to Data Availability)
- 11.7 Customer and Buyer Behavior Analysis
- 11.7.1 Digital Engagement, Customer Experience & Relationship Analysis
- 11.7.2 Customer Buying Behavior & Purchase Decision Analysis
- 11.7.3 Vendor Selection, Supplier Preferences & Future Demand Trends
- 11.7.4 Pricing, Affordability & Value Perception Analysis
- 11.7.5 Customer Segmentation & Demand Pattern Analysis
- 11.8 PESTEL Analysis
- 11.8.1 Political Factors
- 11.8.2 Economic Factors
- 11.8.3 Social Factors
- 11.8.4 Technological Factors
- 11.8.5 Legal Factors
- 11.8.6 Environmental Factors
- 11.9 Industrial Chain Analysis (Subject to Data Availability)
- 11.9.1 Industry Chain Analysis
- 11.9.2 Manufacturing Cost Analysis
- 11.9.3 Supply Side Analysis
- 11.9.3.1 Raw Material Analysis
- 11.9.3.2 Raw Material Procurement Analysis
- 11.9.3.3 Raw Material Price Trend Analysis
- 11.10 Porter’s Five Forces Analysis
- 11.10.1 Bargaining Power of Suppliers
- 11.10.2 Bargaining Power of Buyers
- 11.10.3 Threat of New Entrants
- 11.10.4 Threat of Substitutes
- 11.10.5 Degree of Competition
- 11.11 Patent Analysis (Subject to Data Availability)
- 11.12 ESG Analysis
- 11.13 Geopolitical Outlook
- 11.13.1 Global Power Realignment & Strategic Alliances
- 11.13.2 Geopolitical Risk Landscape & Conflict Hotspots
- 11.13.3 International Trade Relations & Market Access Environment
- 11.13.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
- 11.13.5 Supply Chain Resilience, Localization & Resource Nationalism
- 11.13.6 Technology Sovereignty & Digital Geopolitics
- 11.13.7 Strategic Implications for Investment, Growth & Market Entry
- 11.14 AI & Market Transformation
- 11.14.1 Competitive Landscape Disruption & Strategic Shifts
- 11.14.2 AI-Driven Transformation of Industry Value Chain
- 11.14.3 Evolution of Business Models & Revenue Streams
- 11.14.4 AI-Driven Product, Service & Innovation Transformation
- 11.14.5 Customer Behavior, AI Adoption & Future Market Evolution
Chapter 12. TOP 10 Country Analysis
- 12.1 Country 1
- 12.2 Country 2
- 12.3 Country 3
- 12.4 Country 4
- 12.5 Country 5
- 12.6 Country 6
- 12.7 Country 7
- 12.8 Country 8
- 12.9 Country 9
- 12.10 Country 10
Chapter 13. Research Findings
- 13.1 Key Takeaways
- 13.2 Analyst Point of View
- 13.3 Assumptions and Acronyms
Chapter 14. Research Methodology and Sources
- 14.1 Primary Data Collection
- 14.1.1 Steps for Primary Data Collection
- 14.1.1.1 Identification of KOL
- 14.1.2 Backward Integration
- 14.1.3 Forward Integration
- 14.1.4 How Primary Research Help Us
- 14.1.5 Modes of Primary Research
- 14.1.1 Steps for Primary Data Collection
- 14.2 Secondary Research
- 14.2.1 How Secondary Research Help Us
- 14.2.2 Sources of Secondary Research
- 14.3 Data Validation
- 14.3.1 Data Triangulation
- 14.4 Data Representation
- 14.1 Primary Data Collection
Athenaeum AI Dashboard
Our Proprietary Methodology
Cognitive Market Research and Consulting "The Full Truth" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Chidanand Bilagi and team for the Nitroglycerin API Market Analysis Market analysis.
Primary Intelligence Gathering
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
Secondary Data Triangulation
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
Expert Validation Protocol
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
Athenaeum AI Processing
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
Editorial & QA Review
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
Data Assurance Metrics
Analytical Coverage
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
Sources from the Chemical & Materials Industry
The Three Pillars of End-to-End Market Research Services
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Nitroglycerin API Market Analysis market.
Market Survey
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the nitroglycerin api market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
- Buyer intent & sentiment analysis
- Purchase cycle mapping
- Price sensitivity research
- Channel preference profiling
- Competitive perception study
Customized Market Data & Reports
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
- Ready syndicate report (250+ pages)
- Custom data scope & segmentation
- Excel quantitative models
- Board-ready PPT with key findings
- Secure cloud portal access
Strategic Consultation
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
- Dedicated analyst assigned to you
- Live walkthrough of findings
- Strategic Q&A sessions
- Go-to-market recommendations
- NDA-protected engagement
Customize This Report
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.